Breindahl, T; Kimergård, A; Findal Andreasen, M; Pedersen, DS. Identification of a new psychoactive substance in seized material: the synthetic opioid N-phenyl-N-[1-(2-phenethyl)piperidin-4-yl]prop-2-enamide (Acrylfentanyl). Drug Test. Anal., 1 Mar 2017, 9 (3), 415-422. 516 kB. https://doi.org/10.1002/dta.2046
Rojkiewicz, M; Majchrzak, M; Celiński, R; Kuś, P; Sajewicz, M. Identification and physicochemical characterization of 4-fluorobutyrfentanyl (1-((4-fluorophenyl)(1-phenethylpiperidin-4-yl)amino)butan-1-one, 4-FBF) in seized materials and post-mortem biological samples. Drug Test. Anal., 1 Mar 2017, 9 (3), 405-414. 614 kB. https://doi.org/10.1002/dta.2135
Ziporyn, T. A growing industry and menace: Makeshift laboratory’s designer drugs. JAMA, 12 Dec 1986, 256 (22), 3061–3063. 486 kB. https://doi.org/10.1001/jama.1986.03380220011003
Ohta, H; Suzuki, S; Ogasawara, K. Studies on Fentanyl and Related Compounds IV. Chromatographic and Spectrometric Discrimination of Fentanyl and its Derivatives. J. Anal. Toxicol., 1 Jul 1999, 23 (4), 280-285. 354 kB. https://doi.org/10.1093/jat/23.4.280 #2
Suzuki, S. Studies on fentanyl and related compounds: II. Spectrometric discrimination of five monomethylated fentanyl isomers by gas chromatography/Fourier transform-infrared spectrometry. Forensic Sci. Int., 1 Sep 1989, 43 (1), 15–19. 289 kB. https://doi.org/10.1016/0379-0738(89)90117-5 #a
Vuckovic, S; Prostran, M; Ivanovic, M; Dosen-Micovic, L; Todorovic, Z; Nesic, Z; Stojanovic, R; Divac, N; Mikovic, Z. Fentanyl analogs: Structure-activity-relationship study. Curr. Med. Chem., 1 Jul 2009, 16 (19), 2468–2474. 211 kB. https://doi.org/10.2174/092986709788682074 #1
Spahn, V; Vecchio, GD; Labuz, D; Rodriguez-Gaztelumendi, A; Massaly, N; Temp, J; Durmaz, V; Sabri, P; Reidelbach, M; Machelska, H; Weber, M; Stein, C. A nontoxic pain killer designed by modeling of pathological receptor conformations. Science, 3 Mar 2017, 355 (6328), 966–969. 2.8 MB. https://doi.org/10.1126/science.aai8636 The erratum and revised supplementary material are appended
Anand, JP; Montgomery, D. Multifunctional opioid ligands. In Delta Opioid Receptor Pharmacology and Therapeutic Applications; Jutkiewicz, EM, Ed., Springer Berlin Heidelberg, 20 Apr 2018; pp 21-51. 362 kB. https://doi.org/10.1007/164_2018_104
Mallette, JR; Casale, JF; Toske, SG; Hays, PA. Characterization of (2R,4S)- and (2R,4R)-2-methylfentanyl and their differentiation from cis- and trans-3-methylfentanyl. Forensic Chem., 1 May 2018, 8, 64–71. 1.6 MB. https://doi.org/10.1016/j.forc.2018.02.001 #Fentanyl GC,MS,NMR,IR,other
Higashikawa, Y; Suzuki, S. Studies on 1-(2-phenethyl)-4-(N-propionylanilino)piperidine (fentanyl) and its related compounds. VI. Structure-analgesic activity relationship for fentanyl, methyl-substituted fentanyls and other analogues. Forensic Toxicol., 1 Jun 2008, 26 (1), 1–5. 283 kB. https://doi.org/10.1007/s11419-007-0039-1 #1
EMCDDA. Report on the risk assessment of N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]furan-2-carboxamide (Furanylfentanyl), European Monitoring Centre for Drugs and Drug Addiction, Lisbon, 1 Dec 2017. 728 kB. #Fentanyl
EMCDDA. Report on the risk assessment of N-(1-phenethylpiperidin-4-yl)-phenylacrylamide (Acryloylfentanyl), European Monitoring Centre for Drugs and Drug Addiction, Lisbon, 1 Dec 2017. 919 kB. #Fentanyl MS,NMR,IR
EMCDDA. Report on the risk assessment of N-(4-fluorophenyl)-2-methyl-N-[1-(2-phenylethyl)piperidin-4-yl]propanamide (4F-iBF), European Monitoring Centre for Drugs and Drug Addiction, Lisbon, 1 Jul 2018. 1.2 MB. #Fentanyl
EMCDDA. Report on the risk assessment of N-phenyl-N-[1-(2-phenylethyl)piperidin-4- yl]oxolane-2-carboxamide (THF-F), European Monitoring Centre for Drugs and Drug Addiction, Lisbon, 1 Jul 2018. 549 kB. #Fentanyl
Burns, SM; Cunningham, CW; Mercer, SL. DARK classics in chemical neuroscience: Fentanyl. ACS Chem. Neurosci., 17 Oct 2018, 9 (10), 2428-2437. 1.4 MB. https://doi.org/10.1021/acschemneuro.8b00174 #6
Chambers, SA; DeSousa, JM; Huseman, ED; Townsend, SD. The DARK side of total synthesis: Strategies and tactics in psychoactive drug production. ACS Chem. Neurosci., 17 Oct 2018, 9 (10), 2307–2330. 8.1 MB. https://doi.org/10.1021/acschemneuro.7b00528 #84
Ellis, CR; Kruhlak, NL; Kim, MT; Hawkins, EG; Stavitskaya, L. Predicting opioid receptor binding affinity of pharmacologically unclassified designer substances using molecular docking. PLOS ONE, 24 May 2018, 13 (5), e0197734. 5.5 MB. https://doi.org/10.1371/journal.pone.0197734 #Fentanyl
Cooper, D; Jacob, M; Allen, A. Identification of fentanyl derivatives. J. Forensic Sci., 1 Apr 1986, 31 (2), 511–528. 476 kB. https://doi.org/10.1520/JFS12283J #3 GC,MS,NMR,IR
Wilde, M; Pichini, S; Pacifici, R; Tagliabracci, A; Busardò, FP; Auwärter, V; Solimini, R. Metabolic pathways and potencies of new fentanyl analogs. Front. Pharmacol., 5 Apr 2019, 10 (238). 1.5 MB. https://doi.org/10.3389/fphar.2019.00238 #Fentanyl
Yadav, SK; Kumar, D; Kumar, P; Gupta, PK; Bhattacharya, R. Biochemical, oxidative, and physiological changes caused by acute exposure of fentanyl and its 3 analogs in rodents. Int. J. Toxicol., 1 Jan 2018, 37 (1), 28–37. 423 kB. https://doi.org/10.1177/1091581817750560 #1
Gupta, PK; Yadav, SK; Bhutia, YD; Singh, P; Rao, P; Gujar, NL; Ganesan, K; Bhattacharya, R. Synthesis and comparative bioefficacy of N-(1-phenethyl-4-piperidinyl)propionanilide (fentanyl) and its 1-substituted analogs in Swiss albino mice. Med. Chem. Res., 1 Aug 2013, 22 (8), 3888–3896. 338 kB. https://doi.org/10.1007/s00044-012-0390-6 #Fentanyl MS,NMR,IR
Jimeno, ML; Alkorta, I; Cano, C; Jagerovic, N; Goya, P; Elguero, J; Foces-Foces, C. Fentanyl and its analogue N-(1-Phenylpyrazol-3-yl)-N-[1-(2-phenylethyl)-4-piperidyl]propanamide: 1H- and 13C-NMR Spectroscopy, X-ray crystallography, and theoretical calculations. Chem. Pharm. Bull., 1 Jan 2003, 51 (8), 929–934. 113 kB. https://doi.org/10.1248/cpb.51.929 #1 NMR,other
Blanckaert, P; Cannaert, A; Van Uytfanghe, K; Hulpia, F; Deconinck, E; Van Calenbergh, S; Stove, C. Report on a novel emerging class of highly potent benzimidazole NPS opioids: chemical and in vitro functional characterization of isotonitazene. Drug Test. Anal., 19 Nov 2019, 12 (4), 422-430. 2.6 MB. https://doi.org/10.1002/dta.2738 #Fentanyl LC,MS,NMR,IR
Valdez, CA; Leif, RN; Mayer, BP. An efficient, optimized synthesis of fentanyl and related analogs. PLoS ONE, 18 Sep 2014, 9 (9), e108250. 413 kB. https://doi.org/10.1371/journal.pone.0108250 #4 MS,NMR,TLC,other
Rosas, R; Huang, X; Roth, BL; Dockendorff, C. β-Fluorofentanyls are pH-sensitive mu opioid receptor agonists. ACS Med. Chem. Lett., 12 Sep 2019, 10 (9), 1353–1356. 5.5 MB. https://doi.org/10.1021/acsmedchemlett.9b00335 #1 LC,MS,NMR
Vandeputte, MM; Cannaert, A; Stove, CP. In vitro functional characterization of a panel of non-fentanyl opioid new psychoactive substances. Arch. Toxicol., 1 Nov 2020, 94 (11), 3819–3830. 2.0 MB. https://doi.org/10.1007/s00204-020-02855-7 #B
Clancy, L; Philp, M; Shimmon, R; Fu, S. Development and validation of a color spot test method for the presumptive detection of 25-NBOMe compounds. Drug Test. Anal., 19 Aug 2020, 13 (5), 929-943. 11.3 MB. https://doi.org/10.1002/dta.2905 #Fentanyl
Åstrand, A; Guerrieri, D; Vikingsson, S; Kronstrand, R; Green, H. In vitro characterization of new psychoactive substances at the μ-opioid, CB1, 5HT1A, and 5-HT2A receptors—On-target receptor potency and efficacy, and off-target effects. Forensic Sci. Int., 1 Dec 2020, 317, 110553. 1.7 MB. https://doi.org/10.1016/j.forsciint.2020.110553 #Fentanyl
Allibe, N; Sam-Lai, NF; Willeman, T; Jourdil, J; Bartoli, M; Mallaret, M; Nemoz, B; Stanke-Labesque, F; Eysseric-Guerin, H. Norcarfentanil: Carfentanil misuse or remifentanil treatment? Forensic Toxicol., 1 Jul 2019, 37 (2), 488–495. 687 kB. https://doi.org/10.1007/s11419-019-00481-2 #Fentanyl
Maroge, W; Bordelon, JA; Katz, JM; Zhivago, VR. Large fentanyl and MDA laboratory in Los Angeles, California. JCLIC, 1 Apr 2006, 16 (2), 12–13. 180 kB.
Verougstraete, N; Vandeputte, MM; Lyphout, C; Cannaert, A; Hulpia, F; Van Calenbergh, S; Verstraete, AG; Stove, C. First report on brorphine: The next opioid on the deadly new psychoactive substance horizon? J. Anal. Toxicol., 21 Jan 2021, 44 (9), 937–946. 1.4 MB. https://doi.org/10.1093/jat/bkaa094 #Fentanyl LC,MS,NMR,IR
Devereaux, AL; Mercer, SL; Cunningham, CW. DARK classics in chemical neuroscience: Morphine. ACS Chem. Neurosci., 17 Oct 2018, 9 (10), 2395-2407. 3.0 MB. https://doi.org/10.1021/acschemneuro.8b00150 #14
Otte, L; Wilde, M; Auwärter, V; Grafinger, KE. Investigation of the μ- and κ-opioid receptor activation by eight new synthetic opioids using the [35S]-GTPγS assay: U-47700, isopropyl U-47700, U-49900, U-47931E, N-methyl U-47931E, U-51754, U-48520, and U-48800. Drug Test. Anal., 3 Mar 2022, 14 (4), 1187-1199. 1.9 MB. https://doi.org/10.1002/dta.3238 #II